Jefferies Initiates Coverage On Twist Bioscience with Hold Rating, Announces Price Target of $150

Jefferies analyst Matthew Stanton initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Hold rating and announces Price Target of $150.